2025 was a defining year for Magentus, marked by global accolades, strategic expansion, and transformative digital health innovation. From being named one of TIME’s Top HealthTech Companies to launching award-winning oncology integrations and expanding its presence and footprint across the UK to help support the NHS 10-year-plan, Magentus demonstrated its commitment to smarter, safer, and more connected care.
Global Recognition and Industry Leadership
Magentus earned a spot on TIME Magazine’s prestigious list of the World’s Top HealthTech Companies of 2025, receiving a “Very High” rating in the Health Information & Management category. This recognition placed Magentus among just seven Australian companies on the list and affirmed its leadership in clinical workflow optimisation and secure health information management.
Further cementing its industry influence, Magentus Practice Management & Oncology Managing Director Michele Blanshard was appointed Vice President of the Medical Software Industry Association (MSIA). Her leadership will help shape national policy around interoperability, AI adoption, and clinician usability — key priorities for Australia’s digital health future.
Strategic Growth Through Labflow Acquisition
In a move that further strengthens its diagnostics portfolio, Magentus completed the acquisition of Labflow in late 2025. Labflow, known for its agile laboratory workflow solutions and cloud-native architecture, brings complementary capabilities to Magentus’s Evolution vLab® platform. The acquisition accelerates Magentus’s ability to deliver flexible, interoperable pathology systems across both public and private networks. With Labflow’s expertise in rapid deployment and modular design, Magentus is now positioned to offer enhanced solutions for smaller labs and emerging diagnostic providers, expanding its reach and reinforcing its commitment to innovation across the full spectrum of laboratory services.
Driving Diagnostic Excellence in Partnership with the NHS
Magentus was shortlisted for the HSJ Partnership Award in the category Most Effective Contribution to Clinical Redesign, in partnership with the Cheshire and Merseyside Pathology Network. Co-designed with NHS staff, the unified LIMS solution being recognised supports seamless care across five Trusts, with shared governance and harmonised workflows. Already recognised by NHS England as a model of innovation, the programme is delivering measurable improvements in efficiency, safety, and staff experience, and is positioned to support replication across other regions and networks.
Co-designed with NHS clinicians, Magentus has launched Cris version 3, the next phase of the UK’s most widely used Radiology Information System. The update introduces web-based applications that will enable faster decision-making, better collaboration and a more consistent patient pathway. It reflects Magentus’s ongoing commitment to helping radiology services work more efficiently and deliver consistent patient care.
Award-Winning Oncology Innovation
Another standout moment in 2025 was Charm® being named a winner in the WA Health Excellence Awards under the category “Excellence in Safety and Quality”. This recognition reflects Charm’s transformative impact on cancer care across Western Australia, where it replaced fragmented paper-based systems with a unified digital platform. Implemented across 11 cancer treatment units in partnership with South Metropolitan Health Service (SMHS) and WA Country Health Service (WACHS), Charm® has significantly reduced clinical risk, improved patient outcomes, and modernised chemotherapy management statewide. The nomination underscores Magentus’s commitment to safer, smarter oncology workflows and its leadership in delivering scalable, high-impact digital health solutions.
Charm Evolution® also extended its support for Icon Group – Australia’s largest integrated cancer care provider – and received national approval for electronic prescribing, allowing oncology teams to send prescriptions digitally and securely. This reduces medication errors, speeds up access to treatment, and supports compliance with state-level regulations in Western Australia and Tasmania.
Expanding the Ecosystem: Partnerships That Matter
Magentus deepened its ecosystem through strategic partnerships. A number of popular AI-powered medical scribes were integrated into Gentu, Magentus’s cloud-based practice management platform, allowing specialists to automate clinical note-taking and reduce documentation time. These integrations reflect Magentus’s commitment to clinician wellbeing and patient-centred innovation.
In radiology, Magentus launched Australia’s first FHIR-based eRequests solution with Queensland X-Ray and Lumus, streamlining referrals and improving visibility for both clinicians and patients. Alternate Lab Claiming was also introduced, putting patient choice at the heart of the process.
Strategic Expansion
Magentus expanded its UK presence with new offices in London and Manchester, providing vital spaces where our ever-growing expert teams can work together, as well as collaborate with our partners. These new hubs will strengthen our ability to deliver scalable diagnostic solutions, from powering multi-trust pathology networks to enabling AI-driven diagnostics.
In partnership with Annalise.ai, Magentus supported the deployment of AI-assisted lung cancer diagnostics at County Durham and Darlington NHS Foundation Trust, improving diagnostic accuracy and speeding up treatment pathways. Studies have shown this technology delivers a 45 per cent improvement in diagnostic accuracy and a 12 per cent increase in diagnostic efficiency.
Looking Ahead
With the continued rollout of solutions across the UK, Australia, and Asia, Magentus enters 2026 with strong momentum. As healthcare becomes increasingly data-driven and AI-enabled, Magentus remains focused on building platforms that clinicians trust, workflows that work, and a future where healthcare is more intelligent, connected, and human.
